Pulmonary hypertension epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Jose Loyola (talk | contribs) |
||
| Line 13: | Line 13: | ||
===Prevalence=== | ===Prevalence=== | ||
* The [[prevalence]] of pulmonary hypertension is approximately 1.5 per 100,000 individuals. | * The [[prevalence]] of pulmonary hypertension is approximately 1.5-5 per 100,000 individuals.<ref name="pmidhttps://doi.org/10.37765/ajmc.2021.88609">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.37765/ajmc.2021.88609 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | ||
===Age=== | ===Age=== | ||
| Line 20: | Line 20: | ||
===Gender=== | ===Gender=== | ||
* The female-to-male ratio for PH is approximately 1.7:1.<ref name="Rich-1987">{{Cite journal | last1 = Rich | first1 = S. | last2 = Dantzker | first2 = DR. | last3 = Ayres | first3 = SM. | last4 = Bergofsky | first4 = EH. | last5 = Brundage | first5 = BH. | last6 = Detre | first6 = KM. | last7 = Fishman | first7 = AP. | last8 = Goldring | first8 = RM. | last9 = Groves | first9 = BM. | title = Primary pulmonary hypertension. A national prospective study. | journal = Ann Intern Med | volume = 107 | issue = 2 | pages = 216-23 | month = Aug | year = 1987 | doi = | PMID = 3605900 }}</ref> | * The female-to-male ratio for PH is approximately 1.7:1.<ref name="Rich-1987">{{Cite journal | last1 = Rich | first1 = S. | last2 = Dantzker | first2 = DR. | last3 = Ayres | first3 = SM. | last4 = Bergofsky | first4 = EH. | last5 = Brundage | first5 = BH. | last6 = Detre | first6 = KM. | last7 = Fishman | first7 = AP. | last8 = Goldring | first8 = RM. | last9 = Groves | first9 = BM. | title = Primary pulmonary hypertension. A national prospective study. | journal = Ann Intern Med | volume = 107 | issue = 2 | pages = 216-23 | month = Aug | year = 1987 | doi = | PMID = 3605900 }}</ref> | ||
* Idiopathic pulmonary hypertension (IPAH) which is more prevalent in women (3x more common), was considered the most common type of pulmonary arterial hypertension in a French registry. | * Idiopathic pulmonary hypertension (IPAH) which is more prevalent in women (3x more common), was considered the most common type of pulmonary arterial hypertension in a French registry. Usually it affects women between 30-60 years.<ref name="pmidhttps://doi.org/10.37765/ajmc.2021.88609">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.37765/ajmc.2021.88609 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | ||
*Males often face worse prognosis.<ref name="pmidhttps://doi.org/10.37765/ajmc.2021.88609">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.37765/ajmc.2021.88609 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | |||
==References== | ==References== | ||
Revision as of 09:31, 3 May 2021
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension epidemiology and demographics |
|
Pulmonary hypertension epidemiology and demographics in the news |
|
Blogs on Pulmonary hypertension epidemiology and demographics |
|
Risk calculators and risk factors for Pulmonary hypertension epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ralph Matar
Overview
Pulmonary arterial hypertension has been considered as a disease of young women. The mean age of patients in the U.S. registry was 36 years and the overall female-to-male ratio was 1.7:1.
Epidemiology and Demographics
Incidence
- While previously considered a rare disease, the most recent evidence from a French registry suggests that the incidence of new cases of pulmonary arterial hypertension is 0.20-0.30 cases per 100,000 individuals.[1]
Prevalence
- The prevalence of pulmonary hypertension is approximately 1.5-5 per 100,000 individuals.[2]
Age
- Pulmonary hypertension usually develops between the ages of 20 and 60, but it can occur at any age. The mean age of patients in the U.S. registry was approximately 36 years.[1]
Gender
- The female-to-male ratio for PH is approximately 1.7:1.[1]
- Idiopathic pulmonary hypertension (IPAH) which is more prevalent in women (3x more common), was considered the most common type of pulmonary arterial hypertension in a French registry. Usually it affects women between 30-60 years.[2]
- Males often face worse prognosis.[2]
References
- ↑ 1.0 1.1 1.2 Rich, S.; Dantzker, DR.; Ayres, SM.; Bergofsky, EH.; Brundage, BH.; Detre, KM.; Fishman, AP.; Goldring, RM.; Groves, BM. (1987). "Primary pulmonary hypertension. A national prospective study". Ann Intern Med. 107 (2): 216–23. PMID 3605900. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 2.2 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.37765/ajmc.2021.88609 Check
|pmid=value (help).